Surgery Partners Inc
NASDAQ:SGRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Surgery Partners Inc
Cash & Cash Equivalents
Surgery Partners Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Surgery Partners Inc
NASDAQ:SGRY
|
Cash & Cash Equivalents
$239.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
15%
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Cash & Cash Equivalents
$137.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
8%
|
|
|
Encompass Health Corp
NYSE:EHC
|
Cash & Cash Equivalents
$72.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
2%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Cash & Cash Equivalents
$3B
|
CAGR 3-Years
57%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Cash & Cash Equivalents
$940m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
1%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Cash & Cash Equivalents
$503.9m
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
28%
|
|
Surgery Partners Inc
Glance View
Surgery Partners Inc., a prominent player in the healthcare industry, orchestrates a robust network of surgical facilities across the United States. The company's business model is centered around operating and acquiring a variety of healthcare services, primarily focusing on short-stay surgeries through its ambulatory surgery centers, surgical hospitals, and ancillary services. Founded in 2004, Surgery Partners has grown its footprint by honing in on cost-effective, high-quality outpatient surgery, offering a compelling alternative to traditional hospital settings. This approach not only reduces healthcare costs for patients and insurers but also provides an efficient model for physicians looking to practice in specialized surgical environments. Revenue generation for Surgery Partners is multifaceted, deriving primarily from patient service fees and strategic partnerships with healthcare providers and insurers. By maintaining a diversified portfolio that includes musculoskeletal surgeries, cardiac procedures, and other specialist operations, the company captures a broad spectrum of medical needs. Additionally, it benefits from ancillary services such as anesthesia and pathology, which are critical components of the surgical process. This integrated service offering allows Surgery Partners to maximize revenue streams while maintaining a strong presence in the outpatient surgery market. The company’s collaborative approach, working closely with physicians and leveraging strategic acquisitions, fortifies its position as a leader in the evolution toward more efficient, patient-centric healthcare delivery.
See Also
What is Surgery Partners Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
239.9m
USD
Based on the financial report for Dec 31, 2025, Surgery Partners Inc's Cash & Cash Equivalents amounts to 239.9m USD.
What is Surgery Partners Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
15%
Over the last year, the Cash & Cash Equivalents growth was -11%. The average annual Cash & Cash Equivalents growth rates for Surgery Partners Inc have been -5% over the past three years , -5% over the past five years , and 15% over the past ten years .